Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Development of angioplasty spawned 40 years of innovation, exploration
• 2 decades of diabetes and CVD
• Cardiac arrhythmias: An emerging issue with anticancer drugs Javid J. Moslehi, MD; Joe-Elie Salem, MD, PhD
• 50 years of heart transplant: Progress in immunosuppression, survival rates
• Family history may predict CHD in South Asians
• Sex disparities remain in CHD risk factor management
• Tai chi viable option for patients declining cardiac rehabilitation
• ABRIDGE-J: Dabigatran lowers bleeding risk in ablation for nonvalvular AF
• Bariatric surgery an effective strategy to improve BP control in obese hypertensive patients
• BRUISE CONTROL-2: Device pocket hematoma risk low for any anticoagulation strategy during surgery
• CANTOS: Magnitude of CRP reduction linked with canakinumab clinical benefit
• CULPRIT-SHOCK: Culprit lesion only may be superior to immediate multivessel PCI
• DACAB: Ticagrelor plus aspirin improves saphenous vein graft patency at 1 year post-CABG
• High-dose pitavastatin benefits Japanese population with CAD
• Men more likely than women to receive bystander CPR
• ORBITA puts spotlight on PCI vs. sham procedure
• SENIOR: PCI with DES, short DAPT confers improved outcomes in older patients
• TNT-POAF: Botulinum toxin may reduce postoperative AF
• Trial Scorecard: CULPRIT-SHOCK
• Trial Scorecard: DACAB
• Trial Scorecard: DKCRUSH-V
• Trial Scorecard: HOPE-Duchenne
• Trial Scorecard: PROPEL
• Trial Scorecard: REDUCE LAP-HF
• Trial Scorecard: TRICS III
• Trial Scorecard: ORBITA